LONDON (ShareCast) - (Sharecast News) - Drugmaker Hikma Pharmaceuticals revealed on Tuesday that chief executive Siggi Olafsson has resigned from both the role and the company's board of directors in order to pursue other opportunities.
Hikma, which has initiated an externally facilitated process to replace Olafsson, stated chairman Said Darwazah will assume all CEO responsibilities.

Olafsson will remain available to the group until he departs on 24 June.

Darwazah said: "On behalf of Hikma's board and the entire group, I would like to thank Siggi for his leadership over the past four years. Together with the executive committee, he has worked tirelessly to drive strategic momentum across all three businesses, especially during the challenging days of the pandemic. Hikma is on a strong footing and well-positioned for future growth, and we wish Siggi well for the future".



Reporting by Iain Gilbert at Sharecast.com

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE